Skip to main content
Top
Published in: International Journal of Colorectal Disease 12/2008

01-12-2008 | Original Article

Intraabdominal septic complications following bowel resection for Crohn’s disease: detrimental influence on long-term outcome

Authors: Igors Iesalnieks, Alexandra Kilger, Heidi Glaß, Rene Müller-Wille, Frank Klebl, Claudia Ott, Ulrike Strauch, Pompiliu Piso, Hans J. Schlitt, Ayman Agha

Published in: International Journal of Colorectal Disease | Issue 12/2008

Login to get access

Abstract

Background

A number of studies deal with factors affecting postoperative recurrence; however, they do not analyze the influence of postoperative morbidity on the long-term outcome. This was the aim of the present study.

Materials and methods

Two hundred eighty-two patients underwent 331 intestinal resections for primary or recurrent Crohn’s disease between 1992 and 2005. Closure of ileostomy or colostomy, isolated stricturoplasty, abdominoperineal resection for perianal disease, and reoperations for postoperative complications were excluded. “Surgical recurrence” was defined as a development of stricturing or perforating disease necessitating repeat surgical therapy.

Results

Anastomotic leak, intraabdominal abscess, enterocutaneous fistula (intraabdominal septic complications, IASC) occurred after 46 operations (16%). Four patients died (1.2%). By multivariate analysis, articular disease manifestation (p = 0.03), duration of symptoms leading to surgery (p = 0.009), and weight loss (p = 0.03) were associated with occurrence of postoperative complications. Surgical recurrence occurred following 86 bowel resections, and 36 occurred during the first postoperative year. The following factors were associated with an increased risk of surgical recurrence by multivariate analysis: postoperative IASC (p = 0.0002) and previous bowel resections (p = 0.002). Patients suffering IASC had statistically significantly higher 1-, 2-, 5-, and 10-year surgical recurrence rate (25%, 29%, 50%, and 57%) than patients without IASC (4%, 7%, 19%, and 38%, p = 0.0003).

Conclusion

The incidence of the postoperative IASC is predominantly determined by preoperative disease severity. IASC have a detrimental influence on the long-term outcome following intestinal resections in patients with Crohn’s disease, leading to increased number of repeat resection surgery.
Literature
1.
go back to reference Olaison G, Sjödahl R, Tagesson C (1990) Glucocorticoid treatment in ileal Crohn’s disease: relief of symptoms but not of endoscopically viewed inflammation. Gut 31:325–328PubMedCrossRef Olaison G, Sjödahl R, Tagesson C (1990) Glucocorticoid treatment in ileal Crohn’s disease: relief of symptoms but not of endoscopically viewed inflammation. Gut 31:325–328PubMedCrossRef
2.
go back to reference Dietz DW, Laureti S, Strong SA et al (2001) Safety and longterm efficacy of strictureplasty in 314 patients with obstructing small bowel Crohn’s disease. J Am Coll Surg 192:330–337PubMedCrossRef Dietz DW, Laureti S, Strong SA et al (2001) Safety and longterm efficacy of strictureplasty in 314 patients with obstructing small bowel Crohn’s disease. J Am Coll Surg 192:330–337PubMedCrossRef
3.
go back to reference Tay GS, Binion DG, Eastwood D et al (2003) Multivariate analysis suggests improved perioperative outcome in Crohn’s disease patients receiving immunomodulator therapy after segmental resection and/or strictureplasty. Surgery 134:565–572PubMedCrossRef Tay GS, Binion DG, Eastwood D et al (2003) Multivariate analysis suggests improved perioperative outcome in Crohn’s disease patients receiving immunomodulator therapy after segmental resection and/or strictureplasty. Surgery 134:565–572PubMedCrossRef
4.
go back to reference Yamamoto T, Allan RN, Keighley MR (2000) Risk factors for intra-abdominal sepsis after surgery in Crohn’s disease. Dis Colon Rectum 43:1141–1145PubMedCrossRef Yamamoto T, Allan RN, Keighley MR (2000) Risk factors for intra-abdominal sepsis after surgery in Crohn’s disease. Dis Colon Rectum 43:1141–1145PubMedCrossRef
5.
go back to reference Penner RM, Madsen KL, Fedorak RN (2005) Postoperative Crohn’s disease. Inflamm Bowel Dis 11:765–777PubMedCrossRef Penner RM, Madsen KL, Fedorak RN (2005) Postoperative Crohn’s disease. Inflamm Bowel Dis 11:765–777PubMedCrossRef
6.
go back to reference Landsend E, Johnson E, Johannessen HO et al (2006) Long-term outcome after intestinal resection for Crohn’s disease. Scand J Gastroenterol 41:1204–1208PubMedCrossRef Landsend E, Johnson E, Johannessen HO et al (2006) Long-term outcome after intestinal resection for Crohn’s disease. Scand J Gastroenterol 41:1204–1208PubMedCrossRef
7.
go back to reference Yamamoto T (2005) Factors affecting recurrence after surgery for Crohn’s disease. World J Gastroenterol 11:3971–3979PubMed Yamamoto T (2005) Factors affecting recurrence after surgery for Crohn’s disease. World J Gastroenterol 11:3971–3979PubMed
8.
go back to reference Holzheimer RG, Molloy RG, Wittmann DH (1995) Postoperative complications predict recurrence of Crohn’s disease. Eur J Surg 161:129–135PubMed Holzheimer RG, Molloy RG, Wittmann DH (1995) Postoperative complications predict recurrence of Crohn’s disease. Eur J Surg 161:129–135PubMed
9.
go back to reference Caprilli R, Gassull MA, Escher JC, European Crohn’s and Colitis Organisation et al (2006) European evidence based consensus on the diagnosis and management of Crohn’s disease: special situations. Gut 55(Suppl 1):36–58CrossRef Caprilli R, Gassull MA, Escher JC, European Crohn’s and Colitis Organisation et al (2006) European evidence based consensus on the diagnosis and management of Crohn’s disease: special situations. Gut 55(Suppl 1):36–58CrossRef
10.
go back to reference Alves A, Panis Y, Bouhnik Y et al (2007) Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn’s disease: a multivariate analysis in 161 consecutive patients. Dis Colon Rectum 50:331–336PubMedCrossRef Alves A, Panis Y, Bouhnik Y et al (2007) Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn’s disease: a multivariate analysis in 161 consecutive patients. Dis Colon Rectum 50:331–336PubMedCrossRef
11.
go back to reference Bruewer M, Utech M, Rijcken EJ et al (2003) Preoperative steroid administration: effect on morbidity among patients undergoing bowel resection for Crohn’s disease. World J Surg 27:1306–1310PubMedCrossRef Bruewer M, Utech M, Rijcken EJ et al (2003) Preoperative steroid administration: effect on morbidity among patients undergoing bowel resection for Crohn’s disease. World J Surg 27:1306–1310PubMedCrossRef
12.
go back to reference Post S, Betzler M, von Ditfurth B et al (1991) Risks of intestinal anastomoses in Crohn’s disease. Ann Surg 213:37–42PubMedCrossRef Post S, Betzler M, von Ditfurth B et al (1991) Risks of intestinal anastomoses in Crohn’s disease. Ann Surg 213:37–42PubMedCrossRef
13.
go back to reference Heimann TM, Greenstein AJ, Mechanic L et al (1985) Early complications following surgical treatment for Crohn’s disease. Ann Surg 201:494–498PubMedCrossRef Heimann TM, Greenstein AJ, Mechanic L et al (1985) Early complications following surgical treatment for Crohn’s disease. Ann Surg 201:494–498PubMedCrossRef
15.
go back to reference Simillis C, Purkayastha S, Yamamoto T et al (2007) A meta-analysis comparing conventional end-to-end anastomosis vs. other anastomotic configurations after resection in Crohn’s disease. Dis Colon Rectum 50:1674–1687PubMedCrossRef Simillis C, Purkayastha S, Yamamoto T et al (2007) A meta-analysis comparing conventional end-to-end anastomosis vs. other anastomotic configurations after resection in Crohn’s disease. Dis Colon Rectum 50:1674–1687PubMedCrossRef
16.
go back to reference Smedh K, Andersson M, Johansson H et al (2002) Preoperative management is more important than choice of sutured or stapled anastomosis in Crohn’s disease. Eur J Surg 168:154–157PubMedCrossRef Smedh K, Andersson M, Johansson H et al (2002) Preoperative management is more important than choice of sutured or stapled anastomosis in Crohn’s disease. Eur J Surg 168:154–157PubMedCrossRef
17.
go back to reference Waitzberg DL, Saito H, Plank LD et al (2006) Postsurgical infections are reduced with specialized nutrition support. World J Surg 30:1592–1604PubMedCrossRef Waitzberg DL, Saito H, Plank LD et al (2006) Postsurgical infections are reduced with specialized nutrition support. World J Surg 30:1592–1604PubMedCrossRef
18.
go back to reference Colombel JF, Loftus EV Jr, Tremaine WJ et al (2004) Early postoperative complications are not increased in patients with Crohn’s disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 99:878–883PubMedCrossRef Colombel JF, Loftus EV Jr, Tremaine WJ et al (2004) Early postoperative complications are not increased in patients with Crohn’s disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 99:878–883PubMedCrossRef
19.
go back to reference Pearson DC, May GR, Fick GH et al (1995) Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med 123:132–142PubMed Pearson DC, May GR, Fick GH et al (1995) Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med 123:132–142PubMed
20.
go back to reference Sandborn WJ (1997) Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn’s disease. Am J Gastroenterol 92:876–879PubMed Sandborn WJ (1997) Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn’s disease. Am J Gastroenterol 92:876–879PubMed
21.
go back to reference Feagan BG, Rochon J, Fedorak RN, The North American Crohn’s Study Group et al (1995) Investigators Methotrexate for the treatment of Crohn’s disease. N Engl J Med 332:292–297PubMedCrossRef Feagan BG, Rochon J, Fedorak RN, The North American Crohn’s Study Group et al (1995) Investigators Methotrexate for the treatment of Crohn’s disease. N Engl J Med 332:292–297PubMedCrossRef
22.
go back to reference Greenberg GR, Feagan BG, Martin F, Canadian Inflammatory Bowel Disease Study Group et al (1994) Oral budesonide for active Crohn’s disease. N Engl J Med 331:836–841PubMedCrossRef Greenberg GR, Feagan BG, Martin F, Canadian Inflammatory Bowel Disease Study Group et al (1994) Oral budesonide for active Crohn’s disease. N Engl J Med 331:836–841PubMedCrossRef
23.
go back to reference Present DH, Rutgeerts P, Targan S et al (1999) Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Engl J Med 340:1398–1405PubMedCrossRef Present DH, Rutgeerts P, Targan S et al (1999) Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Engl J Med 340:1398–1405PubMedCrossRef
24.
go back to reference Williams AJ, Palmer KR (1991) Endoscopic balloon dilatation as a therapeutic option in the management of intestinal strictures resulting from Crohn’s disease. Br J Surg 78:453–454PubMedCrossRef Williams AJ, Palmer KR (1991) Endoscopic balloon dilatation as a therapeutic option in the management of intestinal strictures resulting from Crohn’s disease. Br J Surg 78:453–454PubMedCrossRef
25.
go back to reference Cosnes J, Nion-Larmurier I, Beaugerie L et al (2005) Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery. Gut 54:237–241PubMedCrossRef Cosnes J, Nion-Larmurier I, Beaugerie L et al (2005) Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery. Gut 54:237–241PubMedCrossRef
26.
go back to reference Fichera A, Peng SL, Elisseou NM et al (2007) Laparoscopy or conventional open surgery for patients with ileocolonic Crohn’s disease? A prospective study. Surgery 142:566–571PubMedCrossRef Fichera A, Peng SL, Elisseou NM et al (2007) Laparoscopy or conventional open surgery for patients with ileocolonic Crohn’s disease? A prospective study. Surgery 142:566–571PubMedCrossRef
27.
go back to reference Alves A, Panis Y, Bouhnik Y et al (2005) Factors that predict conversion in 69 consecutive patients undergoing laparoscopic ileocecal resection for Crohn’s disease: a prospective study. Dis Colon Rectum 48:2302–2308PubMedCrossRef Alves A, Panis Y, Bouhnik Y et al (2005) Factors that predict conversion in 69 consecutive patients undergoing laparoscopic ileocecal resection for Crohn’s disease: a prospective study. Dis Colon Rectum 48:2302–2308PubMedCrossRef
28.
go back to reference Hildebrandt U, Pistorius G, Lindemann W et al (1995) Laparoscopic resections in Crohn disease. Chirurg 66:807–812PubMed Hildebrandt U, Pistorius G, Lindemann W et al (1995) Laparoscopic resections in Crohn disease. Chirurg 66:807–812PubMed
Metadata
Title
Intraabdominal septic complications following bowel resection for Crohn’s disease: detrimental influence on long-term outcome
Authors
Igors Iesalnieks
Alexandra Kilger
Heidi Glaß
Rene Müller-Wille
Frank Klebl
Claudia Ott
Ulrike Strauch
Pompiliu Piso
Hans J. Schlitt
Ayman Agha
Publication date
01-12-2008
Publisher
Springer-Verlag
Published in
International Journal of Colorectal Disease / Issue 12/2008
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-008-0534-9

Other articles of this Issue 12/2008

International Journal of Colorectal Disease 12/2008 Go to the issue